Matthew Mercer, Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 2703 Riverwood Ave, Lumberton, NC 28358 Phone: 912-658-2009 |
News Archive
In a study that included nearly 18,000 children who had cancer, with follow-up of about 25 years, the greatest excess risk associated with a subsequent primary neoplasm (a new tumor) at older than age 40 years was for digestive and genitourinary neoplasms (related to the genital or urinary tract organs), according to a study in the June 8 issue of JAMA, a theme issue on cancer.
Senate Majority Leader Harry Reid (D-Nev.) has said that he will attempt to bring legislation that would reauthorize the President's Emergency Plan for AIDS Relief to the Senate floor on Wednesday, CQ Today reports (Graham-Silverman, CQ Today, 6/24).
Wound Management Technologies, Inc. announced today that its CellerateRx product, distributed through its subsidiary Wound Care Innovations, LLC, will be highlighted in a presentation at the 23rd Annual Symposium on Advanced Wound Care and Wound Healing Society meeting April 17-20 in Orlando, Florida.
VeriChip Corporation ("VeriChip") (NASDAQ: CHIP) and its development partner RECEPTORS LLC, a technology company whose AFFINITY by DESIGN™ chemistry platform can be applied to the development of selective binding products, announced today that VeriChip has been granted an exclusive license to RECEPTORS' Patent No. 7,504,364 titled "Methods of Making Arrays and Artificial Receptors" and Patent No. 7,469,076 "Sensors Employing Combinatorial Artificial Receptors," in their application to the development of the virus triage detection system for the H1N1 virus.
VaxInnate Corporation announced today that VAX125, its investigational prototype vaccine for seasonal flu, has been named one of the Top 10 Infectious Diseases Projects to Watch in 2011 by Elsevier Business Intelligence and the Windhover Conferences.
› Verified 9 days ago